Last update :
08/05/2024
Anxiolytic   Clorazepate di potassium  
Injection
Stability in solutions Stability of mixtures Factors which affect stability Compatibility Route of administration References Pdf
   Chemical structure  

Tradename   Tradename     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Tranxene France, Luxembourg, Netherlands, Poland, Portugal, Tunisia
Tranxilium Austria, Germany, Spain, Switzerland
Stability of mixtures   Injection   Stability of mixtures : Clorazepate di potassium     
Container Solvent Concentration Compound Temperature Storage Duration of stability References
Polyvinyl chloride NaCl 0,9% or Glucose 5% 0,08 mg/ml
Injection   Clorazepate di potassium   
Injection   Citalopram 0,16 mg/ml
20°C-25°C
4 Hour
Light 1604
Level of evidence D

  Mentions Légales